Kronos Bio
kronosbio.comLocations
United States · North America · San Mateo, CA, USA
industry
Health · Biotechnology · DeepTech
Size
51-200 employees
Stage
IPO
founded in
2017
Kronos Bio focuses on the research and development of first-in-class therapies that modulate historically recalcitrant cancer targets. It develops therapies that modulate historically undruggable targets. The company leverages deep capabilities in high-throughput small-molecule microarrays (SMM), targeted protein degradation, and cancer biology in order to identify potent and selective compounds against transcription factors and other central drivers of oncogenic signaling.
Something looks off?Open jobs at Kronos Bio